Apoglyx

About:

Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.

Website: http://www.apoglyx.com/

Top Investors: Almi Invest, LU Innovation

Description:

Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.

Total Funding Amount:

6M SEK

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Lund, Skane Lan, Sweden

Founded Date:

2015-01-01

Contact Email:

pbn(AT)apoglyx.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2021-10-25

IPO Status:

Private

Industries: